US stocks were somewhat mixed with most major indices marginally higher, although the tech-heavy Nasdaq 100 underperformed, while sectors saw an upward bias with Healthcare outperforming and buoyed by Moderna surging in excess of 165% after a cancer breakthrough drug trial with Merck. Nonetheless, the main story on Wednesday was the US Treasury announcing it is increasing, by at least double, the size of liquidity support buyback operations for longer-dated nominal coupon securities, from the current USD 2bln to at least USD 4bln. Following this update, US Treasury yields fell, particularly in the long end, while the Dollar saw notable…
News Timeline:
Track the development of this news story across the Internet.